Form 4: Natera CFO Sells Shares Under 10b5-1 Trading Plan

Natera's Chief Financial Officer, Michael Burkes Brophy, sold 1,442 shares of common stock at $161.87 per share on January 27, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Burkes Brophy, the Chief Financial Officer of Natera, Inc., executed a sale of company stock.
• The transaction involved the sale of 1,442 shares of Natera common stock.
• The sale price was $161.87 per share.
• The transaction occurred on January 27, 2025.
• This sale was conducted under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2023.
• Following the transaction, Mr. Brophy directly owns 108,032 shares of Natera stock.

Sentiment

Score: 5

Explanation: The document is a routine Form 4 filing for an insider stock sale under a pre-arranged plan. It doesn't indicate any positive or negative sentiment, but is a neutral event.

Risks

• Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors. The use of 10b5-1 plans is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The sale of shares by a CFO is not unusual, and the use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations.
• Comparable companies often see similar filings from their executives, indicating routine transactions rather than any specific negative signal.

Stakeholder Impact

• The sale of shares by a company executive may cause some minor short-term fluctuations in the stock price, but is unlikely to have a significant long-term impact on stakeholders.

Key Dates

Keywords

Natera, NTRA, insider trading, Form 4, stock sale, Rule 10b5-1, Michael Burkes Brophy, CFO